| RYCMX | RYVLX | RYCMX / RYVLX | |
| Total Expense Ratio | 2.39 | 1.74 | 137% |
| Annual Report Gross Expense Ratio | 2.52 | 1.87 | 135% |
| Fund Existence | 26 years | 22 years | - |
| Gain YTD | 24.832 | 18.430 | 135% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.91M | 1.59B | 0% |
| Annual Yield % from dividends | 0.94 | 0.00 | - |
| Returns for 1 year | 45.60 | 26.31 | 173% |
| Returns for 3 years | 55.33 | 112.92 | 49% |
| Returns for 5 years | -31.70 | 81.53 | -39% |
| Returns for 10 years | 31.26 | 882.86 | 4% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FRETX | 37.07 | 0.23 | +0.62% |
| Franklin Equity Income C | |||
| JSJAX | 16.32 | 0.03 | +0.18% |
| JHancock Small Cap Dynamic Growth A | |||
| VVIAX | 85.78 | -0.24 | -0.28% |
| Vanguard Morn Value Index Admiral | |||
| VSFIX | 29.69 | -0.10 | -0.34% |
| Federated Hermes MDT Small Cap Value IS | |||
| PHLAX | 37.97 | -0.44 | -1.15% |
| PGIM Jennison Health Sciences A | |||